ASCO® 2026 Highlights: Presenter Vignette – Bjørn Grønberg

Dr. Bjørn Grønberg

Bjørn Grønberg

MD, PhD

St. Olav's Hospital

LBA8005

Concurrent thoracic radiotherapy (TRT), platinum/etoposide chemotherapy, and durvalumab immunotherapy in extensive-stage (ES) small cell lung cancer (SCLC): A phase III trial.